Century Therapeutics officer proposes $5.77K sale

Accepted by SEC EDGAR 06/12/2026 - 03:35 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Century Therapeutics, Inc. (IPSC) officer Gregory Russotti reported a proposed sale of 2,584 common shares, with an aggregate market value of $5,767.75 and an approximate sale date of June 12, 2026. The shares were acquired from the issuer on June 11, 2026 through restricted stock vesting as compensation. The notice says the sale includes an amount necessary to cover a tax obligation resulting from settlement of a vested equity award distribution. It also lists prior sales of 10,076 shares on March 12, 2026 and 524 shares on June 8, 2026.

Key Figures

Proposed shares to be sold: 2,584 common shares Aggregate market value: $5,767.75 Shares acquired through restricted stock vesting: 2,584 shares +4 more

7 metrics

Proposed shares to be sold 2,584 common shares Approximate sale date: June 12, 2026

Aggregate market value $5,767.75 Proposed sale of 2,584 common shares

Shares acquired through restricted stock vesting 2,584 shares Acquired from the issuer on June 11, 2026 as compensation

Prior shares sold 10,076 shares March 12, 2026; gross proceeds of $25,685.74

Gross proceeds $25,685.74 Sale of 10,076 shares on March 12, 2026

Prior shares sold 524 shares June 8, 2026; gross proceeds of $1,106.01

Gross proceeds $1,106.01 Sale of 524 shares on June 8, 2026

Key Terms

Restricted Stock Vesting, vested equity award distribution, Gross Proceeds

3 terms

Restricted Stock Vesting financial

"Nature of Acquisition Transaction: Restricted Stock Vesting"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

vested equity award distribution financial

"settlement of a vested equity award distribution"

Gross Proceeds financial

"Amount of Securities Sold | Gross Proceeds"

The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares does Gregory Russotti plan to sell of IPSC?

Gregory Russotti is listed as proposing to sell 2,584 common shares with an aggregate market value of $5,767.75. The approximate sale date is June 12, 2026, through Fidelity Brokerage Services LLC. The shares were acquired from Century Therapeutics on June 11, 2026 through restricted stock vesting as compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001867305
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Century Therapeutics, Inc.
SEC File Number	001-40498
Address of Issuer	25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PENNSYLVANIA 19104
Phone	215-981-4000
Name of Person for Whose Account the Securities are To Be Sold	Russotti Gregory
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2584	5767.75	180354809	06/12/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/11/2026	Restricted Stock Vesting	Issuer			2584	06/11/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Gregory Russotti 25 N 38th Street 11th Floor Philadelphia PA 19104	Common	03/12/2026	10076	25685.74
Gregory Russotti 25 N 38th Street 11th Floor Philadelphia PA 19104	Common	06/08/2026	524	1106.01

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	06/12/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Adam Gehring, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Gregory Russotti
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)